Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality

Andrea Natali1, Antonio L'Abbate, Ele Ferrannini

  • 1Department of Internal Medicine, University of Pisa, Italy. anatali@ifc.cnr.it

European Heart Journal
|March 27, 2003
PubMed

Insights

The erythrocyte sedimentation rate (ESR) is linked to coronary atherosclerosis (ATS) and predicts cardiac death in men. Higher ESR levels indicate more severe ATS and increased risk of mortality.

Area of Science:

  • Cardiology
  • Clinical Pathology
  • Epidemiology

Background:

  • Coronary atherosclerosis (ATS) is a leading cause of cardiac mortality.
  • The erythrocyte sedimentation rate (ESR) is a common inflammatory marker.
  • The relationship between ESR and ATS extension, and its predictive value for cardiac mortality, requires further investigation.

Purpose of the Study:

  • To determine if ESR is associated with the extent of coronary atherosclerosis (ATS).
  • To evaluate whether ESR predicts cardiac mortality in patients undergoing angiography.

Main Methods:

  • Retrospective observational cohort study of 1726 patients undergoing coronary angiography.
  • ESR levels were analyzed in relation to the number of diseased coronary vessels.
  • Cardiac mortality was assessed over a median follow-up of 92 months.

Main Results:

  • ESR was progressively higher with increasing severity of coronary ATS (1, 2, or 3-vessel disease).
  • ESR showed a positive association with ATS, independent of other risk factors.
  • Patients in the highest ESR quartile had a 1.72-fold increased odds of cardiac mortality.

Conclusions:

  • ESR is an independent correlate of coronary ATS.
  • ESR predicts cardiac death in male patients with probable ischemic heart disease (IHD).
  • ESR may serve as a valuable prognostic marker in cardiovascular disease.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495